Opinion: More accountability needed in how drugs are priced and reimbursed
23 May 2016Lawrence King (Department of Sociology) and Piotr Ozieranski (University of Bath) discuss how EU member states use complex policy instruments to determine how much they are willing to pay the pharmaceutical industry for its products.